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Abstract Micronucleus (MN) assay has been extensively
used in detection of DNA damage, instability in cancer, and
genetic disorders. In the current study, MN, binucleated
cells, and nuclear division index (NDI) were investigated
in Iraqi patients with thyroid disorders. The results indicated
significantly (p<0.05) increased binucleated cells with mi-
cronucleus (BNMN) frequencies in thyroid cancer group
(37.58±3.07) versus other thyroid disorder groups (6.60±
1.29, 14.90±1.69, 15.56±1.76). On the other hand, the
frequency of micronucleus per 1,000 and the NDI were
significantly (p<0.05) decreased in hypothyroidism (MN
1.55±0.36) (NDI 0.009±0.001) versus other thyroid disor-
der groups (MN: 6.05±0.97, 6.09±0.53, 5.34±0.56) (NDI:
0.049±0.003, 0.032±0.002, 0.025±0.002), with no differ-
ence versus healthy group (0.0±0.0). The number of BNMN
and MN are parallel to the severity of thyroid disorders which
were 6.60±1.29, 14.90±1.69, 15.56±1.76, and 37.58±3.07 for
hypothyroidism, thyroid toxic goiter, thyroid nontoxic goiter,
and thyroid cancer, respectively. The number of BNMN and
MN are parallel to the severity of thyroid disorders which were
6.60±1.29, 14.90±1.69, 15.56±1.76, and 37.58±3.07 for hy-
pothyroidism, thyroid toxic goiter, thyroid nontoxic goiter, and
thyroid cancer, respectively. The results also indicate that there
were no significant differences among age and sex groups as
related with BNMN formation within each thyroid disorder
groups and healthy control group.
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Introduction
Chromosomal damages measurement is one of important
ways to evaluate the toxicity, carcinogenicity, and mutagenic-
ity of drugs, chemicals, and rays (Cotterill et al. 2001; Ge et al.
2005; Gad and Saad 2008). Such damages were also detected
to associate with some diseases and cancer (Fenech 2000; Neri
et al. 2005; El-Zein et al. 2008, 2011). Most of these damages
appeared as gene mutations and chromosomal rearrangements
or appeared as free genetic particles near nucleus such as
micronucleus or genetic balls distributed along cell cytoplasm
such as double minutes (Gil et al. 2000; Herrmann 2003;
Joseph et al. 2009). Many protocols were used to evaluate
the genetic effects of these harmful factors; most of them are
long, complicated, and costly assays. Micronucleus assay
proofed to be the preferred method for assessing chromosome
damage because they enable both chromosome loss and chro-
mosome breakage to be measured reliably (Fenech 2000;
2002; Joseph et al. 2009). Micronucleus (MN) is arise during
cell division when a whole lagging acentric chromosome or
chromosome with nonfunctional centromere or damaged
chromosomes (Leach and Cook 2004; AlFaisal 2007;
AlFaisal et al. 2010). These oval or circular bodies do not
integrate to the daughter nuclei and appeared as highly stained
bodies beside nucleus membrane. The principle of the micro-
nucleus assay is by adding of cytochalasin B to the cell
cultures to block cytokinesis cell cultures which lead to the
formation of micronuclei in bi- or multinucleated interphase
cells (Fenech 2000). This assay has been extensively used in
routine mutagen and carcinogen screening protocols to detect
factors and agents that cause chromosomal damages and
cytological toxicity as well to evaluate the genetical and
A. H. M. AlFaisal (*) : I. A. R. Abdul-Hassan
Genetic Engineering and Biotechnology Institute, Baghdad, Iraq
e-mail: alfais2000@yahoo.com
I. J. K. AL-Ramahi
Al-Razi Centre for Medical Diagnostic kits Production,
Ministry of Industry, Baghdad, Iraq
Comp Clin Pathol (2014) 23:683–688
DOI 10.1007/s00580-012-1671-7
cytological damages to lymphocytes of cancer patients before
and after radiotherapy (Hooman et al. 2008). Recently,
COMETassay was applied to detect DNA damages in thyroid
patients before and after treatment (Ge et al. 2005).
The present study was performed to determine the genetic
damages and DNA instability via MN assay associated with
various types of thyroid disorders.
Material and methods
Subjects
Five study groups have been investigated. Apparently
healthy control group consists of 25 healthy individuals of
different ages. No obvious abnormalities were selected from
blood bank donors for comparison. One hundred patients
with thyroid disorders who attend the endocrinologist in
Nuclear Medicine Hospital and Al Yarmok Nuclear
Medicine Department in Baghdad, Iraq were selected.
Clinical, ultrasonication, and serum thyroid hormones were
used for diagnosis. Healthy controls and patients’ ages
ranged from 17 to 79 years. All patients were suffering from
thyroid disorders such as toxic goiter, thyroid nontoxic
goiter, thyroid hypothyroidism, and thyroid cancer in
Baghdad during a period from July 2009 to October 2009.
Blood samples
Venous blood sample (3 ml) was collected in heparinized
tubes by trained nurses from each individual of both thyroid
disorder and healthy control groups.
Blood culture protocol
Blood culture protocol was done according to Fenech
(2000). A 0.5-ml blood sample was added to culture tubes
containing 4.5 ml of RPMI 1640 media enriched with 20 %
fetal calf serum and 0.2 ml of phytohemagglutinin 1 % in
each. Tubes were mixed gently by inverting a few minutes
and incubated for 44 h at 37 °C in a slant position.
Cytochalasin B was then added to each culture at a concen-
tration of 3 μg/ml to block cell cytokinesis, and cultures
were reincubated at 37 °C for further 28 h. Cells were then
harvested by centrifugation at 2,000 rpm for 10 min.
Supernatant was discarded by pipetting the media, leaving
a little medium as possible over the cell pellet. Cell pellet
was resuspended in the supernatant remains, and 10 ml of
warm hypotonic (0.075 M KCl) solution was added gently
to each tube. Tubes were then mixed and incubated for
30 min in a water bath at 37 °C. The tubes were centrifuged
at 2,000 rpm for 10 min; the supernatant was discarded; and
the pellet was resuspended in the supernatant remains, and
5 ml of fixative solution was added gently to each tube.
Tubes were kept in refrigerator for about 30 min. The tubes
were centrifuged, and the supernatant was discarded.
Fixation steps were repeated for three more times. After
the final centrifugation, the cells were resuspended in a
small volume of fixative solution (approximately 0.5–
1 ml) depending on the size of cell bottom to give a slightly
opaque suspension.
Slide preparation and estimation
Slides were prepared in order to examine the micronuclei
formation and the nuclear division index. Before use, the
slides were cleaned well with methanol then with distilled
water. After that, the fixed lymphocyte cells were dropped
from about 30-cm height using a Pasteur pipette onto slides
which were dried at 37 °C (Lamberti et al. 1983), stained
with Giemsa stain, and examined by light microscope (×40
and×100). At least 1,000 binucleated cells per duplicate cell
culture were scored to assess the frequency of cells with
one, two, or more than two micronuclei. Additionally, the
cells were classified as mononucleates, binucleates, or mul-
tinucleates (Kirsch-Volders et al. 1997). The frequency of
binucleate and micronuclei were calculated as follow:
Binucleated cells with micronucleus BNMNð Þ
1; 000 binucleated cells 1; 000 BNð Þ=
Number of MN 1; 000 binucleated cells 1; 000 BNð Þ=
Nuclear division index
The proliferation index was estimated by measuring the
nuclear division index according to Lamberti et al. (1983).
NDI ¼ 1 M1%ð Þ þ 2 M2%ð Þ þ 3 M3%ð Þ þ 4 M4%ð Þ½  N=
MN ¼ 1 MN1ð Þ þ 2 MN2ð Þ þ 3 MN3ð Þ þ 4 MN4ð Þ N=½ 
NDI Nuclear division index.
M, 1, 2, 3, 4 Number of binucleated cells with
micronucleus.
MN, 1, 2, 3, 4 Number of micronucleus in
binucleated cells.
N Total number of cells.
Results
A total number of BNMN per 1,000 and MN per 1,000 were
calculated for each patient group and compared with healthy
(control) group (Fig. 1).
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The numbers of micronuclei per 1,000, binucleated cell
with micronuclei per 1,000, and NDI in peripheral blood
lymphocytes of Iraqi thyroid disorders compared with
healthy control group are summarized in Table 1.
The results indicated significantly (p<0.05) increased
BNMN frequencies in thyroid cancer group (37.58±3.07)
versus hypothyroidism, thyroid toxic goiter, and thyroid
nontoxic goiter groups (6.60±1.29, 14.90±1.69, and 15.56±
1.76, respectively). Also, significant (p<0.05) increase in
other thyroid disorder groups versus healthy control (0.0±
0.0) were observed. While the frequency of micronucleus
per 1,000 significantly (p<0.05) decreased in hypothyroidism
(1.55±0.36) versus other thyroid disorder groups (6.05±0.97,
6.09±0.53, 5.34±0.56), with no difference in the frequency of
micronucleus per 1,000 between hypothyroidism group and
healthy group (0.0±0.0). In addition, there were no significant
differences in micronuclei per 1,000 among thyroid cancer,
thyroid toxic goiter, and nontoxic goiter (6.05±0.97, 6.09±
0.53, and 5.34±0.56 respectively).
The NDI frequencies were significantly decreased in
hypothyroidism (0.009±0.001) compared with thyroid can-
cer, thyroid toxic, and nontoxic goiter groups (0.049±0.003,
0.032±0.002, and 0.025±0.002, respectively). There is no
significant difference in NDI frequencies among thyroid
cancer, thyroid toxic, and thyroid nontoxic goiter (0.049±
0.003, 0.032±0.002, and 0.025±0.002, respectively).
The number of BNMN and MN are parallel to the sever-
ity of thyroid disorders which were 6.60±1.29, 14.90±1.69,
15.56±1.76, and 37.58±3.07 for hypothyroidism, thyroid
toxic goiter, thyroid nontoxic goiter, and thyroid cancer,
respectively.
Tables 2 and 3 illustrated results of related micronuclei
formation rates with age and sex groups. There were no
significant differences among age and sex groups as related
with BNMN formation within each thyroid disorder groups
and healthy control group (Table 2).
Discussion
MN frequency is a biomarker of chromosomal damage,
genome instability, and cancer risk that integrates acquired
mutations and genetic susceptibility (Fenech 2000; Joseph
et al. 2009). In addition, the NDI and the proportion of
binucleated cells are biomarkers of mutagen response and
immune function in lymphocytes as well as cytostatic
effects of agents (Kocaman et al. 2008; Bonassi et al.
2011; El-Zein et al. 2011). In thyroid disorders, micronucle-
us assay was used as well to other cytogenetic assays such
as chromosomal aberrations assay (Wilkens et al. 2000;
Hooman et al. 2008), micronuclei assays associated with
fluorescence in situ hybridization (FISH) ( Joseph et al.
2009), and COMET assay (Ge et al. 2005).
The current results indicated that significantly increased
BNMN frequencies in thyroid cancer group versus other
thyroid disorder groups which reflect a high proliferative
rate, high level of genetic damage and cytotoxicity of can-
cer, and less rate but significant in other groups. The results
Fig. 1 Binucleate (BN) cells
with Micronucleus (MN) in
thyroid disorders patients
(×100)
Table 1 Frequency of BNMN, MN, and NDI (mean ± SE) among Iraqi thyroid disorders patients and apparently healthy control
Groups NDI Micronucleus MN/1,000 BNMN/1,000
Hypothyroidism 0.009±0.001 b 1.55±0.36 b 6.60±1.29 c
Thyroid Cancer 0.049±0.003 a 6.05±0.97 a 37.58±3.07a
Thyroid Toxic goiter 0.032±0.002 a 6.09±0.53 a 14.90±1.69 b
Thyroid Nontoxic goiter 0.025±0.002 a 5.34±0.56 a 15.56±1.76 b
Healthy control 0.000±0.000 c 0.0±0.0 b 0.000±0.000 d
Significant differences at (p<0.05). Different letters refer to significant differences among means
BNMN Binucleate cells with micronucleus, MN Micronucleus, NDI Nuclear Division Index
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also showed that a significant number of micronuclei and
NDI was detected in all thyroid disorder groups versus
healthy. The NDI was significantly higher in cancer, toxic
goiter, and nontoxic goiter than hypothyroidism and healthy
control. These results indicated a high DNA instability and
DNA damages associated with thyroid disorders especially
in thyroid cancer and toxic goiter which may reflect the
possibility of chronic exposure to genotoxic agents such as
radiations. Such genotoxicity was also detected as mutations
in TPO and TG genes among Iraqi thyroid disorders patients
(AlFaisal et al. 2012; Al-Ramahi et al. 2012). After Gulf war
I in 1981, Gulf war II in 1991, and Gulf war III in 2003, the
Iraqi environment radiation contamination was well docu-
mented (Al-Azzawi and Al-Saji 1999; IFAM 1995; Al-
Azzawi et al. 1999, 2002; Butrus et al. 2002), and the
incidences of various types of cancer and genetic disorders
due to this contamination were arisen (Al-Sadoon et al.
1998; Yaqoub et al. 1998a, b, 1999, 2002; Ali and Al-Ali
2002). This possibility is supported by the genotoxicity
associated with radiations which were observed by several
studies. Such studies have investigated the level of genome
damage and micronucleus in thyroid cancer patients envi-
ronmentally exposed to radiation after the Chernobyl fallout
(Sbrana et al. 2006; Tronko et al. 2007; Cardis and Hatch
2011), after Fukushema in Japan (Medalia 2011), in patients
affected by thyroid cancer who underwent radiotherapy
(Livingston et al. 1993; Gutierrez et al. 1997, 1999;
Dardano et al. 2007; Hooman et al. 2008), and in people
affected by thyroid nodules following occupational expo-
sure to ionizing radiation (Brooks et al. 2007; Scarpato et al.
2009).
The results of the current study also showed that no
significant differences among age and sex groups as related
with BNMN formation within each thyroid disorder groups
and healthy control group. These results are correspondents
to those by Scarpato et al. (2011) who reported that gender
and age did not cause variation in the MN baseline level.
Other literature regarding gender and MN showed that the
Table 2 Frequencies of BNMN,
MN, and NDI (mean ± SE)
among Iraqi thyroid disorders
patients according to age
Ns nonsignificant
Group\Parameter Age year
<30 30–50 >50 LSD (ns)
Hypothyroidism
BNMN/1,000 1.00±0.18 1.50±0.32 2.16±0.83 2.003
MN/1,000 7.00±2.86 6.50±1.50 6.33±2.95 7.370
NDI 0.009±0.002 0.009±0.001 0.01±0.004 0.009
Thyroid cancer
BNMN/1,000 7.00±2.79 5.72±1.20 6.00±1.00 7.160
MN/1,000 37.50±4.33 39.27±4.14 28.50±11.50 20.541
NDI 0.042±0.002 0.051±0.004 0.052±0.002 0.022
Thyroid toxic goiter
BNMN/1,000 6.25±0.81 6.68±0.82 4.57±0.97 2.738
MN/1,000 12.12±3.58 14.31±1.76 19.42±4.85 9.032
NDI 0.034±0.004 0.0034±0.003 0.026±0.004 0.011
Thyroid nontoxic goiter
BNMN/1,000 3.50±1.50 4.94±0.73 6.15±0.95 4.249
MN/1,000 19.50±13.50 15.94±2.88 14.46±1.64 12.812
NDI 0.026±0.016 0.024±0.003 0.026±0.003 0.019
Table 3 Frequencies of BNMN, MN, and NDI (mean ± SE) between
males and females of Iraqi thyroid disorders patients
Group\Parameter Males Females LSD (ns)
Hypothyroidism
BNMN/1,000 1.66±0.95 1.50±0.35 1.767
MN/1,000 6.83±3.09 6.50±1.38 6.506
NDI 0.009±0.001 0.010±0.004 0.008
Thyroid Cancer
BNMN/1,000 6.83±1.81 5.63±1.19 4.853
MN/1,000 41.66±3.80 35.36±4.24 13.923
NDI 0.032±0.002 0.032±0.003 0.009
Thyroid Toxic Goiter
BNMN/1,000 5.16±0.42 6.68±0.80 2.151
MN/1,000 12.58±1.79 16.36±2.49 7.096
NDI 0.032±0.003 0.0.032±0.002 0.009
Thyroid Nontoxic Goiter
BNMN/1,000 3.50±1.19 5.60±0.61 3.488
MN/1,000 6.50±2.53 16.85±1.87 10.519
NDI 0.03±0.002 0.013±0.005 0.015
Ns nonsignificant, BNMN Binucleated cells with micronucleus, MN
Micronucleus, NDI Nucleic Division Index
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frequencies of MN are greater in females than in males
(Thierens et al. 2000; Joseph et al. 2009).
Open Access This article is distributed under the terms of the Creative
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